Gene · 309
Papers2,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Co-expression of the Mammaglobin (SCGB2A2) Gene With hsa-miR-184 and hsa-miR-190b Indicates Its Possible Role in Oncogenic Pathways in Breast Cancer. | Cancer Diagn Progn | 2026 | 42683286 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Cardiovascular Disease: Intercellular Signaling, Liquid Biopsy Biomarkers, and Therapeutic Translation. | Circ Res | 2026 | 42594169 | PubTator, text mining | PubMed |
| Synovial fluid proteomic biomarkers in periprosthetic joint infection: A systematic review with gene ontology and protein network analyses. | J Exp Orthop | 2026 | 42519810 | PubTator, text mining | PubMed |
| Excess muscle plasma membrane leak disrupts ECM content and shifts macrophage-mediated muscle repair. | JCI Insight | 2026 | 42406575 | PubTator, text mining | PubMed |
| Annexin A6 Is a Novel Cytosolic Regulator of Multiple Inter-organelle Contact Sites. | Contact (Thousand Oaks) | 2026 | 42404214 | PubTator, text mining | PubMed |
| Differential Biological and Molecular Profiling of Mesenchymal Progenitor Cells in Cartilage from Osteoarthritis and Rheumatoid Arthritis: An In Vitro Study. | Int J Mol Sci | 2026 | 42352972 | PubTator, text mining | PubMed |
| Annexin A6 controls multi-organelle contact site formation and endolysosomal positioning, and remodels the STARD3 interactome. | iScience | 2026 | 42338474 | PubTator, text mining | PubMed |
| Annexin A6 Modulates the Secretion of Pro-Inflammatory Cytokines and Exosomes via Interaction with SNAP23 in Triple-Negative Breast Cancer Cells. | Cells | 2026 | 42274606 | PubTator, text mining | PubMed |
| Correction: Mechanism of interaction between ANXA6 and cGAS to regulate STING signaling pathway and promote ferroptosis in cervical cancer. | Cancer Cell Int | 2026 | 42021345 | PubTator, text mining | PubMed |
| Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer. | Int J Mol Sci | 2026 | 41977343 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Mediated Nucleolin Transfer in Glioblastoma: A Targetable Axis Driving Blood-Tumour Barrier Formation. | J Extracell Vesicles | 2026 | 41926335 | PubTator, text mining | PubMed |
| Multi-omics integration reveals ANXA6-high γδ T cell-endothelial communication as a potential link between periodontitis and MASLD. | NPJ Syst Biol Appl | 2026 | 41876560 | PubTator, text mining | PubMed |
| Reprogramming the immunosuppressive breast cancer microenvironment: integrating cellular, metabolic, and stromal targets for rational immunotherapy. | Front Immunol | 2026 | 41766877 | PubTator, text mining | PubMed |
| Exosomes and Triple-Negative Breast Cancer: Current Knowledge and Clinical Significance. | Int J Mol Sci | 2026 | 41752055 | PubTator, text mining | PubMed |
| A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells Lacking Annexin A1. | Cells | 2026 | 41744829 | PubTator, text mining | PubMed |
| Docosahexaenoic acid supplementation inhibits monocyte exhaustion memory formation during sepsis. | Inflamm Res | 2026 | 41703318 | PubTator, text mining | PubMed |
| Mass spectrometry-based human spatial omics: fundamentals, innovations, and applications. | J Biomed Sci | 2026 | 41645178 | PubTator, text mining | PubMed |
| PARP inhibitors restore NK cell function via secretory crosstalk with tumor cells in prostate cancer. | J Clin Invest | 2026 | 41591831 | PubTator, text mining | PubMed |
| Comprehensive Profiling of Annexins in Neuromuscular Disorders Reveals a Unique Signature in Dysferlinopathy. | Eur J Neurol | 2025 | 41327964 | PubTator, text mining | PubMed |
| Identifying Predictive Biomarkers for Sepsis in Trauma-Induced Systemic Inflammatory Response Syndrome Using Proteomics Data. | J Surg Res | 2025 | 41317596 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/309/papers